Social and behavioral correlates of pelvic inflammatory disease

Sexually Transmitted Diseases

Volumn 25, Issue 7, 1998, Pages 378-385

  Aral, Sevgi O ^a   Wasserheit, Judith N ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENCE; ARTICLE; CHLAMYDIASIS; FEMALE; GENITAL TRACT INFECTION; GONORRHEA; HEALTH CARE ACCESS; HUMAN; PELVIC INFLAMMATORY DISEASE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVICITIS;

CHLAMYDIA INFECTIONS; FEMALE; HUMANS; PELVIC INFLAMMATORY DISEASE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SOCIAL BEHAVIOR; UTERINE CERVICAL DISEASES;

EID: 0031872972     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199808000-00010     Document Type: Article

References (59)

1. Washington AE, Aral SO, Wolner-Hanssen P, Grimes DA, Holmes KK. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA 1991; 266:2581-2586.
2. Padian N, Hitchcock PJ, Fullilove RE III, Kohlstadt V, Brunham R, the NIAID Study Group on Integrated Behavioral Research for Prevention and Control of Sexually Transmitted Diseases. Issues in defining behavioral risk factors and their distribution. Sex Trans Dis 1990; 17:200-204.
3. Wasserheit JN, Aral SO. The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies. J Infect Dis 1996; 174(Suppl 2):S201-S213.
4. Aral SO, Holmes KK, Padian N, Cates W. Overview: Individual and population level approaches to the epidemiology and prevention of sexually transmitted diseases and human immunodeficiency virus infection. J Infect Dis 1996; 174(Suppl 2):S127-S133.
5. Koopman JS, Longini IM. The ecological effects of individual exposures and nonlinear disease dynamics in populations. Am J Public Health 1994; 84:836-842.
6. Susser M, Susser E. Choosing a future for epidemiology. I. Eras and paradigms. Am J Public Health 1996; 86:668-673.
7. Susser M, Susser E. Choosing a future for epidemiology. II. from black box to Chinese boxes and eco-epidemiology. Am J Public Health 1996; 86:674-677.
8. Koopman JS. Comment: emerging objectives and methods in epidemiology. Am J Public Health 1996; 86:630-632.
9. Wolner-Hanssen P, Kiviat NB, Holmes KK. Atypical pelvic inflammatory disease: a subacute, chronic, or subclinical upper genital tract infection in women. In: Holmes KK, Mardh P-A, Sparling PF, Wiesner PJ, eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill Information Services, 1990:615-620.
10. Aral SO, Mosher WD, Cates W. Self-reported pelvic inflammatory disease in the United States, 1988. JAMA 1991; 266:2570-2573.
11. Hillis SD, Wasserheit JN. Screening for chlamydia - a key to the prevention of pelvic inflammatory disease. N Engl J Med 1996; 334:1399-1401.
12. Schachter J, Stoner E, Moncada J. Screening for chlamydia infections in women attending family planning clinics. West J Med 1983; 138:375-379.
13. Greenberg JB, Magder L, Aral SO. Age at first coitus: a marker for risky sexual behavior in women. Sex Trans Dis 1992; 19:331-334.
14. Upchurch D, Brady W, Reichart C, Hook E. Behavioral contribution to acquisition of gonorrhea in patients attending an inner city sexually transmitted diseases clinic. J Infect Dis 1990; 161:938-941.
15. Cates W Jr, Rolfs RT Jr, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol Rev 1990; 12:199-220.
16. Wolner-Hanssen P, Eschenbach DA. Paavonen J, et al. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 1990; 263:54-59.
17. Marchbanks PA, Lee NC, Peterson HB. Cigarette smoking as a risk factor for pelvic inflammatory disease. Am J Obstet Gynecol 1990; 162:639-644.
18. Lee NC, Rubin GL, Borucki R.The intrauterine device and pelvic inflammatory disease revisited: new results from the women's health study. Obstet Gynecol 1988; 72:1-6.
19. Klovdahl AS. Social networks and the spread of infectious disease: the AIDS example. Soc Sci Med 1985; 21:1203-1216.
20. Centers for Disease Control. Condoms for prevention of sexually transmitted diseases. MMWR 1988; 37:133-137.
21. Stone KR, Grimes DA, Magder LS. Personal protection against sexually transmitted diseases. Am J Obstet Gynecol 1986; 155:180-188.
22. Austin H, Louv WC, Alexander WJ. A case-control study of spermicides and gonorrhea. JAMA 1984; 251:2822-2824.
23. Kelaghan J, Rubin GL, Ory HW, et al. Barrier-method contraceptives and pelvic inflammatory disease. JAMA 1982; 248:184-187.
24. Orr DP, Langefeld CD, Katz BP, Gaine VA. Behavioral intervention to increase condom use among high-risk female adolescents. J Pediatr 1996; 128:288-295.
25. Zenilman JM, Weisman CS, Rompalo AM, et al. Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Trans Dis 1995; 22:15-21.
26. Aral SO, Peterman TA. Measuring outcomes of behavioural interventions for STD/HIV prevention. Int J AIDS 1996; 7(Suppl. 2):30-38.
27. Evans BA, Tasker T, MacRae KD. Risk profiles for genital infection in women. Genitourin Med 1993; 69:257-261.
28. Messiah A, Blin P, Fiche V, ACSF group. Sexual repertoires of heterosexuals: implications for HIV/sexually transmitted disease risk and prevention. AIDS 1995; 9:1357-1365.
29. Foxman B, Aral SO, Holmes KK. Heterosexual repertoire is associated with same-sex experience. Sex Trans Dis 1998; 5:1-5.
30. American Social Health Association. Teenagers know more than adults about STDs, but knowledge among both groups is low. ASHA STD News 1996; 3:1.
31. Hillis S, Harms L, Marchbanks P, Amsterdam L, MacKenzie W. Recurrent chlamydia infections as a risk factor for ectopic pregnancy. In: Orfila J, Byrne GI, Chernesky MA, Grayston JT, Jones RB, Ridgway GL, Saikku P, Schachter J, Stamm WE, Stephen RS, eds. Chlamydial Infections. Proceedings of the Eighth International Symposium on Human Chlamydial Infections. France: Societa Editrice Esculapio, 1994:611-613.
32. Oh KM. Risk for gonococcal (GC) & chlamydial (CT) cervicitis in adolescents: incidence and recurrence in a prospective cohort study (Abstract no. 178). In: Programs and Abstracts of the 11th Meeting of the International Society for STD Research. New Orleans, LA, August 30, 1995.
33. Ellen JM, Hessol NA, Kohn RP, Bolan GA. Sociodemographic predictors of repeat STD infections in San Francisco, 1989-1993 (Abstract no. 173). In: Programs and Abstracts of the 11th Meeting of the International Society for STD Research. New Orleans, LA, August 30, 1995.
34. Marrazzo JA. Risk factors for recurrent chlamydial infection in women attending family planning clinics (Abstract no. 175). In: Programs and Abstracts of the 11th Meeting of the International Society for STD Research. New Orleans, LA, August 30, 1995.
35. Courtney J. Risk factors for repeat gonorrhea and chlamydial infections in Los Angeles (Abstract no. 174). In: Programs and Abstracts of the 11th Meeting of the International Society for STD Research. New Orleans, LA, August 30, 1995.
36. Fortenberry JD, Brizendine EJ, Katz BP, Blythe M, Orr DP. Recurrent sexually transmitted infections (STI) among adolescent females (Abstract no. 172). In: Programs and Abstracts of the 11th Meeting of the International Society for STD Research. New Orleans, LA, August 30, 1995.
37. Ripa T. Public healthcare against C. Trachomatis, a case to win. The Swedish experience and model calculations (Abstract no. 254). In: Programs and Abstracts of the 11th Meeting of the International Society for STD Research. New Orleans, LA, August 30, 1995.
38. Herrmann B, Egger M. Genital chlamydia trachomatis (Ct) infections in Uppsala County, Sweden 1985-1993: has a changed STD legislation contributed to declining rates? (Abstract no. 259). In: Programs and Abstracts of the 11th Meeting of the International Society for STD Research. New Orleans, LA, August 30, 1995.
39. Aavitsland P, Lystad A. Controlling chlamydia the Norway (Abstract no. 255). In: Programs and Abstracts of the 11th Meeting of the International Society for STD Research. New Orleans, LA, August 30, 1995.
40. Blythe MJ, Katz BP, Batteiger BE, Ganser JA, Jones RB. Recurrent genitourinary chlamydial infections in sexually active female adolescents. J Pediatr 1992; 121:487-493.
41. Suchman EA. Stages of illness and medical care. J Health Soc Behav 1965; 6:114-128.
42. Harrisson RM. Women's treatment decisions for genital symptoms. J R Soc Med 1982; 75:23-26.
43. Leenaars PEM, Rombouts R, Kok G. Seeking medical care for a sexually transmitted disease: determinants of delay-behavior. Psychol Health 1993; 8:17-32.
44. Timko C. Seeking medical care for a breast cancer symptom: determinants of intentions to engage in prompt or delay-behavior. Health Psychol 1987; 6:305-328.
45. Fortenberry JD. Health care seeking behaviors related to sexually transmitted diseases among adolescents. Am J Public Health 1997; 87:417-420.
46. Cheng TL, Savageau JA, Sattler AL, DeWitt TG. Confidentiality in health care. A survey of knowledge, perceptions, and attitudes among high school students. JAMA 1993; 269:1404-1407.
47. Irwin DE. Self-treatment patterns and medical-care seeking behavior in STD patients. (Abstract #20). In: Programs and Abstracts of the 11th Meeting of the International Society for STD Research. New Orleans, LA, August 30, 1995.
48. Brookoff D. Compliance with doxycycline therapy for outpatient treatment of pelvic inflammatory disease. South Med J 1994; 87:1088-1091.
49. Southwick KL, MacKay T, Levine W. Management of pelvic inflammatory disease in emergency rooms: findings from the national hospital ambulatory medical care survey. EIS Conference, April 22-26, 1996. Atlanta, GA.
50. Stoner BP. The health care consumer-health care provider interface: facilitators and impediments to STD care. Paper presented at the American Public Health Association Annual Meeting, November 2, 1995, San Diego, CA.
51. Hook EW III, Spitters C, Reichart CA, Neumann TM, Quinn TC. Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA 1994; 272:867-870.
52. Hessol NA, Priddy FH, Bolan G, Baumrind N, Vittinghoff E, Reingold AL, Padian NS. Management of pelvic inflammatory disease by primary care physicians: a comparison with centers for disease control and prevention guidelines. Sex Trans Dis 1996; 23:157-163.
53. Centers for Disease Control and Prevention. Pelvic inflammatory disease: guidelines for the prevention and management. MMWR 1991; 40(RR-5):1-25
54. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection. N Engl J Med 1996; 334:1362-1366.
55. Hessol NA, Vittinghoff E, Bolan G, Padian NS. (1995) Risk factors for pelvic inflammatory disease (PID) (Abstract no. 285). In: Programs and Abstracts of the 11th Meeting of the International Society for STD Research. New Orleans, LA, August 30, 1995.
56. Scholes D, Daling JR, Stergachis A, Weiss NS, Wang S-P, Grayston T. Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol 1993; 81:601-606.
57. Baird DD, Weinberg CR, Voigt LF, Daling JR. Vaginal douching and reduced fertility. Am J Public Health 1996; 86:844-850.
58. Washington AE, Sweet RL, Shafer MA. Pelvic inflammatory disease and its sequelae in adolescents (review). J Adolesc Health Care 1985; 298:298-310.
59. Spence MR, Adler J, McLellan R. Pelvic inflammatory disease in the adolescent. J Adolesc Health Care 1990; 11:304-309.